Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder

Molecular Neurobiology

Volumn 27, Issue 2, 2003, Pages 137-151

  Lai, Yuan Yang ^a   Siegel, Jerome M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lewy bodies; Lewy neurites; Locus coeruleus; Nucleus magnocellularis; REM sleep behavior disorder; Retrorubral nucleus; Substantia nigra; Ventral tegmental area; synuclein

Indexed keywords

BRAIN REGION; BRAIN STEM; CAT; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; HUMAN; LEWY BODY; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MUSCLE CONTRACTION; NERVE CELL DEGENERATION; NERVE PROJECTION; NEURITE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; PARASOMNIA; PARKINSONISM; REM SLEEP; REVIEW;

EID: 0038687021     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:27:2:137     Document Type: Review

References (126)

1. German D. C., Dubach M., Askari S., Apeciale S. G., and Bowden D. M. (1988) 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience 24, 161-174.
2. 3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkin-son's disease. J. Neurochem. 49, 617-621.
3. Lee C. S., Samii A., Sossi V., Ruth T. J., Schulzer M., Holden J. E., et al. (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann. Neurol. 47, 493-503.
4. Varrone A., Marek K. L., Jennings D., Innis R. B., and Seibyl J. P. (2001) [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov. Disord. 16, 1023-1032.
5. Pearce R. K. B., Seeman P., Jellinger K., and Tourtellotte W. W. (1990) Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. Eur. Neurol. 30, Suppl 1, 9-14.
6. Seeman P. and Niznik H. B. (1990) Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J. 4, 2737-2744.
7. 2 sites in Parkinson syndrome of different etiology. Brain Res. 483, 30-38.
8. Hierholzer J., Cordes M., Venz S., Schelosky L., Harisch C., Richter W., et al. (1998) Loss of dopamine-D2 receptor binding sites in parkinsonian plus syndromes. J. Nucl. Med. 39, 954-960.
9. Tachibana M., Tanaka K., Hishikawa Y., and Kaneko Z. (1975) A sleep study of acute psychotic states due to alcohol and meprobamate addiction, in Advances in sleep research, Vol 2 (Weitzman E. D., ed.), New York, Spectrum, pp. 177-203.
10. Schenck C. H., Bundlie S. R., Ettinger M. G., and Mahowald M. W. (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9, 293-308.
11. Eisensehr I., Linke R., Noachtar S., Schwarz J., Gildehaus F. J., and Tatsch K. (2000) Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 123, 1155-1160.
12. Albin R. L., Koeppe R. A., Chervin R. D., Consens F. B., Wernette K., Frey K. A., et al. (2000) Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 55, 1410-1412.
13. Tandberg E., Larsen J. P., and Karlsen K. (1998) A community-based study of sleep disorders in patients with Parkinson's disease. Mov. Disord. 13, 895-899.
14. Bergonzi P., Chiurulla C., Gambi D., Mennuni G., and Pinto F. (1975) L-dopa plus dopadecarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment. Acta Neurol. Belg. 75, 5-10.
15. Kales A., Ansel R. D., Markham C. H., Sharf M. B., and Tan T. I. (1971) Sleep in patients with Parkinson's disease and normal subjects, prior to and following levodopa administration. Clin. Pharmac. Ther. 12, 397-406.
16. Bergonzi P., Chiurulla C., Cianchettti C., and Tempesta E. (1974) Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: The action of L-dopa. Confin. Neurol. 36, 5-22.
17. Mouret J. (1975) Differences in sleep in patients with Parkinson's disease. EEG Clin. Neurophysiol. 38, 653-657.
18. Foley D. J., Monjan A. A., Brown S. L., Simonsick E. M., Wallace R. B., and Blazer D. G. (1995) Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18, 425-432.
19. Barbar S. I., Enright P. L., Boyle P., Foley D., Sharp D. S., Petrovitch H., et al. (2000) Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. J. Gerontol. A Biol. Sci. Med. Sci. 55, 406-411.
20. Schafer D. and Greulich W. (2000) Effects of parkinsonian medication on sleep. J. Neurol. 247 Suppl 4, 24-27.
21. Wetter T. C., Collado-Seidel V., Pollmacher T., Yassouridis A., and Trenkwalder C. (2000) Sleep and periodic leg movement patters in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23, 361-367.
22. Ondo W. G., Dat Vuong K., Khan H., Atassi F., Kwak C., and Jankovic J. (2001) Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57, 1392-1396.
23. Fish D. R., Sawyers D., Allen P. J., Blackie J. D., Lee A. J., and Marsden C. D. (1991) The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia. Arch. Neurol. 48, 210-214.
24. Askenasy J. J. M., Weitzman E. D., and Yahr M. D. (1985) Are periodic movements in sleep a basal ganglia dysfunction? J. Neural Transm. 70, 337-348.
25. Askenasy J. J. M. (1981) Sleep pattern in extrapyramidal disorders. Int. J. Neurol. 15, 62-76.
26. Bliwise D. L., Williams M. L., Irbe D., Ansari F. P., and Rye D. B. (1997) Inter-rater reliability for identification of REM sleep in Parkinson's disease. Sleep 23, 671-676.
27. Askenasy J. J. M. and Yahr M. D. (1985) Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology 35, 527-532.
28. Schenck C. H., Hurwitz T. D., and Mahowald M. W. (1993) REM sleep behavior disorder: an update on a series of 96 patients and a review of the world literature. J. Sleep Res. 2, 224-231.
29. Lapierre O. and Montplaisir J. (1992) Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 42, 1371-1374.
30. Schenck C. H. and Mahowald M. W. (1990) Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Cleveland Clin. J. Med. 57, Suppl S9-S23.
31. Schenck C. H., Bundlie S. R., Patterson A. L., and Mahowald M. W. (1987) Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA 257, 1786-1789.
32. Sforza E., Zucconi M., Petronelli R., Lugaresi E., and Cirignotta F. (1988) REM sleep behavioral disorders. Eur. Neurol. 28, 295-300.
33. Olson E. J., Boeve B. F., and Silber M. H. (2000) Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123, 331-339.
34. Schenck C. H., Hopwood J., Duncan E., and Mahowald M. W. (1992) Preservation and loss of REM atonia in human idiopathic REM sleep behavior disorder (RBD): quantitative polysomnographic (PSG) analyses in 17 patients. Sleep Res. 21, 16.
35. Tachibana N., Kimura K., Kitajima K., Shinde A., Kimura J., and Shibasake H. (1997) REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation. J. Neurol. Neurosurg. Psychiatry 63, 678-681.
36. Salva M.A.Q. and Guilleminault C. (1986) Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia. Neurology 36, 576-577.
37. Tachibana N., Kimura K., Kitajima K., Nagamine T., Kimura J., and Shibasaki H. (1995) REM sleep without atonia at early stage of sporadic olivopontocerebellar atrophy. J. Neurol. Sci. 132, 28-34.
38. Shimizu T., Inami Y., Sugita Y., Iijima S., Teshima Y., et al. (1990) REM sleep without muscle atonia (Stage 1-REM) and its relation to delirious behavior during sleep in patients with degenerative diseases involving the brain stem. Jpn. J. Psychiatry Neurol. 44, 681-692.
39. Halliday G. M., Li Y. W., Blumbergs P. C., Joh T. H., Cotton R. G. H., Howe P.R.C., et al. (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann. Neurol. 27, 373-385.
40. Goto S. and Hirano A. (1991) Catecholaminergic neurons in the parabrachial nucleus of normal individuals and patients with idiopathic Parkinson's disease. Ann. Neurol. 30, 192-196.
41. Patt S. and Gerhard L. (1993) A golgi study of human locus coeruleus in normal brains and in Parkinson's disease. Neuropathol. Appl. Neurobiol. 19, 519-523.
42. Jellinger K. A. (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14, 153-197.
43. Schenck C. H., Garcia-Rill E., Skinner R. D., Anderson M. L., and Mahowald M. W. (1996b) A case of REM sleep behavior disorder with autopsy-confirmed Alzheimer's disease: postmortem brain stem histochemical analyses. Biol. Psychiatry 40, 422-425.
44. Lewy F. H. (1912) Paralysis agitans. I. Pathologische anatomie, in Handbuch der neurologie (Lewandowsky M, ed.), Springer, Berlin, pp. 920-933.
45. Tretiakoff C. (1919) Contribution a l'etude de l'Anatomie pathologique du locus niger de soemmering avec quelques deductions relatives a la pathogenie des troubles du tonus musculaire et de la maladie de Parkinsons. These de Paris.
46. Kosaka K., Yoshimura M., Ikeda K., and Budka H. (1984) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin. Neuropathol. 3, 185-192.
47. Ditter S. M. and Mirra S. S. (1987) Neuropathological and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 37, 754-760.
48. Uchiyama M., Isse K., Tanaka K., Yokota N., Hamamoto M., Aida S., et al. (1995) Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 45, 709-712.
49. Ohama E. and Ikuta F. (1976) Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol. 34, 311-319.
50. Forno L. S. (1986) The Lewy body in Parkinson's disease. Adv. Neurol. 45, 35-43.
51. Turner R. S., D'Amato C. J., Chervin R. D., and Blaivas M. (2000) The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology 55, 1730-1732.
52. Maroteaux L., Campanelli J. T., and Scheller R. H. (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
53. Spillantini M. G., Growther R. A., Jakes R., Hasegawa M., and Goedert M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA 95, 6469-6473.
54. Hishikawa A., Hashizume Y., Yoshida M., and Sobue G. (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease. Neuropathol. Appl. Neurobiol. 27, 362-372.
55. Murphy D. D., Rueter S. M., Trojanowski J. Q., and Lee V.M.Y. (2000) Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214-3220.
56. Jensen P. H., Nielsen M. S., Jakes R., Dotti C. G., and Goedert M. (1998) Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273, 26,292-26,294.
57. Baba M., Nakajo S., Tu P. H., Tomita T., Nakaya K., Lee V. M. Y., et al. (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879-884.
58. Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., and Takahashi H. (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 239, 45-48.
59. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., and Masliah E. (1998) Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am. J. Pathol. 152, 367-372.
60. Braak H., Rub U., Sandmann-Keil D., Gai W. P., de Vos R. A. I., Jansen E. N. H., et al. (2000) Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol. 99, 489-495.
61. Braak H., Sandmann-Keil D., Gai W. P., and Braak E. (1999) Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein immunohistochemistry. Neurosci. Lett. 265, 67-69.
62. 4 (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons. Eur. J. Pharmacol. 136, 31-37.
63. Ballard P. A., Tetrud J. W., and Langston J. W. (1985) Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): 7 cases. Neurology 35, 949-956.
64. Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M., et al. (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiat. Res. 1, 249-254.
65. Forno L. S., Langston J. W., DeLanney L. E., Irwin I., and Ricaurte G. A. (1986) Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann. Neurol. 20, 49-55.
66. Kowall N. W., Hantrye P., Brouillet E., Beal M. F., McKee A. C., and Ferrante R. J. (2000) MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport 11, 211-213.
67. Pungor K., Papp M., Kekesi K., and Juhasz G. (1990) A novel effect of MPTP: the selective suppression of paradoxical sleep in cats. Brain Res. 525, 310-314.
68. Jouvet M. and Delorme J. F. (1965) Locus coeruleus et sommeil paradoxal. C R Seances Soc. Biol. Fil. 159, 895-899.
69. Henley K. and Morrison A. R. (1974) A re-evaluation of the effects of lesions of the pontine tegmentum and locus coeruleus on phenomena of paradoxical sleep in the cat. Acta Neurobiol. Exp. 34, 215-232.
70. Schenkel E. and Siegel J. M. (1989) REM sleep without atonia after lesions of the medial medulla. Neurosci. Lett. 98, 159-165.
71. Shouse M. N. and Siegel J. M. (1992) Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep. Brain Res. 571, 50-63.
72. Holmes C. J. and Jones B. E. (1994) Importance of cholinergic, GABAergic, serotonergic and other neurons in the medial medullary reticular formation for sleep-wake states studied by cytotoxic lesions in the cat. Neuroscience 62, 1179-1200.
73. Hendricks J. C., Morrison A. R., and Mann G. L. (1982) Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res. 239, 81-105.
74. Schenck C. H. and Mahowald M. W. (1996) REM sleep parasomnias. Neurol. Clin. 14, 697-720.
75. Lai Y. Y. and Siegel J. M. (1990) Muscle tone suppression and stepping produced by stimulation of midbrain and rostral pontine reticular formation. J. Neurosci. 10, 2727-2734.
76. Lai Y. Y. and Siegel J. M. (1997) Brainstem-mediated locomotion and myoclonic jerks. I. Neural substrates. Brain Res. 745, 257-264.
77. Dahlstrom A. and Fuxe K. (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. Acta Physiol. Scand. 62 Suppl. 232, 5-78.
78. Wiklund L., Leger L., and Persson M. (1981) Monoamine cell distribution in the cat brain stem. A fluorescence histochemical study with quantification of indolaminergic and locus coeruleus cell groups. J. Comp. Neurol. 203, 613-647.
79. Lai Y. Y., Clements J. R., and Siegel J. M. (1993) Glutamatergic and cholinergic projections to the pontine inhibitory area identified with horseradish peroxidase retrograde transport and immunohistochemistry. J. Comp. Neurol. 336, 321-330.
80. Ford B., Holmes C. J., Mainville L., and Jones B. E. (1995) GABAergic neurons in the rat pontomesencephalic tegmentum: codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. J. Comp. Neurol. 363, 177-196.
81. Stamp J. A. and Semba K. (1995) Extent of colocalization of serotonin and GABA in the neurons of the rat raphe nuclei. Brain Res. 677, 39-49.
82. Vertes R. P. and Crane A. M. (1997) Distribution, quantification, and morphological characteristics of serotonin-immunoreactive cells of the supralemniscal nucleus (B9) and pontomesencephalic reticular formation in the rat. J. Comp. Neurol. 378, 411-424.
83. Magoun H. W. and Rhines R. (1946) An inhibitory mechanism in the bulbar reticular formation. J. Neurophysiol. 9, 165-171.
84. Lai Y. Y., Siegel J. M., and Wilson W. J. (1987) Effect of blood pressure on medial medulla-induced muscle atonia. Am. J. Physiol. 252, H1249-H1257.
85. Hajnik T., Lai Y. Y., and Siegel J. M. (2000) Atonia-related regions in the rodent pons and medulla. J. Neurophysiol. 84, 1942-1948.
86. Lai Y. Y. and Siegel J. M. (1991) Pontomedullary glutamate receptors mediating locomotion and muscle tone suppression. J. Neurosci. 11, 2931-2937.
87. Lai Y. Y. and Siegel J. M. (1992) Corticotropin-releasing factor mediated muscle atonia in pons and medulla. Brain Res. 575, 63-68.
88. Lai Y. Y. and Siegel J. M. (1997) Brainstem-mediated locomotion and myoclonic jerks. II. Pharmacological effects. Brain Res. 745, 265-270.
89. Lai Y. Y., Shalita T., Kodama T., and Siegel J. M. (2001) Neurotoxic lesion of the ventral mesopontine junction induces muscle hyperactivity during sleep. Soc. Neurosci. Abstr. Vol 27, Program # 296.2.
90. Lai Y. Y., Shalita T., Wu J. P., and Siegel J. M. (2002) Neurotoxic lesion of the ventral mesopontine junction induces hypersomnia and muscle hyperacitivity during sleep - an animal model of PLMD and RBD. Sleep 25, A62.
91. Lai Y. Y. and Siegel J. M. (1999) Muscle atonia in REM sleep, in Rapid eye movement sleep. (Mallick B. N. and Inoue S., eds.), Narosa Pub. House, New Delhi, pp. 69-90.
92. Schneider J. S., Yuwiler A., and Markham C. H. (1986) Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry. Exp. Neurol. 91, 293-307.
93. Understedt U. (1968) 6-hydroxydopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5, 107-110.
94. Breese G. R. and Taylor T. D. (1970) Effects of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther. 174, 413-420.
95. Sawynok J. and Reid A. (1996) Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats. J. Pharmacol. Exp. Ther. 277, 646-653.
96. Petitjean F., Laguzzi R., Sordet F., Jouvet M., and Pujol J. F. (1972) Effects de l'injection intraventriculaire de 6-hydroxydopamine. I. Sur les monoamines cerebrales du chat. Brain Res. 48, 281-293.
97. Laguzzi R., Petitjean F., Pujol J. F., and Jouvet M. (1972) Effects de l'injection intraventriculaire de 6-hydroxydopamine. II Sur le cycle veille-sommeils du chat. Brain Res. 48, 295-310.
98. Miller J. D., Farber J., Gatz P., Roffwarg H., and German D. C. (1983) Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res. 273, 133-141.
99. Steinfels G. F., Heym J., Strecker R. E., and Jacobs B. L. (1983) Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res. 258, 217-228.
100. Otterson O. P. and Storm-Mathisen J. (1984) Neurons containing or accumulating transmitter amino acids. In: Handbook of chemical neuroanatomy, (Bjoklund A., and Hokfelt T., Kuhar M. J., eds.), Amsterdam: Elsevier, pp. 141-245.
101. Datta S., Curro Dossi R., Pare D., Oakson G., and Steriade M. (1991) Substantia nigra reticulata neurons during sleep-waking states: relation with ponto-geniculo-occipital waves. Brain Res. 566, 344-347.
102. Szymusiak R. and McGinty D. (1986) Sleep-related neuronal discharge in the basal forebrain of cats. Brain Res. 258, 217-228.
103. Nitz D. and Siegel J. S. (1996) GABA release in posterior hypothalamus across sleep-waking cycle. Am. J. Physiol. 271, R1707-R1712.
104. Lin J. S., Sakai K., Vanni-Mercier G., and Jouvet M. (1989) A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res. 479, 225-240.
105. Lai Y. Y., Shalita T., Hajnik T., Wu J. P., Kuo J. S., Chia L. G., et al. (1999) Neurotoxic N-methyl-D-aspartate lesion of the ventral midbrain and mesopontine junction alters sleep wake organization. Neuroscience 90, 469-483.
106. Lai Y. Y., Clements J. R., Wu X. Y., Shalita T., Wu J. P., Kuo J. S., et al. (1999) Brainstem projections to the ventromedial medulla in cat: retrograde transport horseradish peroxidase and immunohistochemical studies. J. Comp. Neurol. 408, 419-436.
107. Luppi P. H., Aston-Jones G., Akaoka H., Chouvet G., and Jouvet M. (1995) Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris Leucoagglutinin. Neuroscience 65, 119-160.
108. Vertes R. P. and Martin G. F. (1988) Autoradiographic analysis of ascending projections from the pontine and mesencephalic reticular formation and the median raphe nucleus in the rat. J. Comp. Neurol. 275, 511-541.
109. Understedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal doapmine system. Brain Res. 24, 485-493.
110. Carey R. J. (1986) Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxy-dopamine lesions of the substantia nigra. Exp. Neurol. 92, 591-600.
111. Dunbar J. S., Hitchcock K., Latimer M., Rugg E. L., Ward N., and Winn P. (1992) Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following unilateral ibotenate or quinolinate lesions. Brain Res. 589, 194-206.
112. Kiyatkin E. A. and Rebec G. V. (1998) Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats. Neuroscience 85, 1285-1309.
113. Gulley J. M., Kuwajima M., Mayhill E., and Rebec G. V. (1999) Behavior-related changes in the activity of substantia nigra pars reticulata neurons in freely moving rats. Brain Res. 845, 68-76.
114. Kelland M. D. and Asdourian D. (1989) Pedunculopontine tegmental nucleus-induced inhibition of muscle activity in the rat. Behav. Brain Res. 34, 213-234.
115. Lai Y. Y. and Siegel J. M. (1988) Medullary regions mediating atonia. J. Neurosci. 8, 4790-4796.
116. Fung S. J. and Barnes C. D. (1981) Evidence of facilitatory coerulospinal action in lumbar motoneurons of cats. Brain Res. 216, 299-311.
117. Lai Y. Y., Strahlendorf H. K., Fung S. J., and Barnes C. D. (1989) The actions of two monoamines on spinal motoneurons from stimulation of the locus coeruleus in the cat. Brain Res. 484, 268-272.
118. Lai Y. Y., Kodama T., and Siegel J. M. (2001) Changes in monoamine release in the ventral horn and hypoglossal nucleus linked to pontine inhibition of muscle tone: an in vivo microdialysis study. J. Neurosci. 21, 7384-7391.
119. Lai Y. Y., Kodama T., and Siegel J. M. (2000) Suppression of norepinephrine release is linked to the rostral dorsomedial but not ventromedial medulla induced atonia. Soc. Neurosci. Abstr. 26, 693.
120. Kodama T., Lai Y. Y., and Siegel J. M. (2000) Glycine release is increased in the ventral horn and hypoglossal motoneuron pools during rostromedial medulla-induced atonia. Soc. Neurosci. Abstr. 26, 693.
121. Eisensehr I., v Lindeiner H., Jager M., and Noachtar S. (2001) REM sleep behavior in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography? J. Neurol. Sci. 186, 7-11.
122. Schenck C. H., Bundlie S. B., and Mahowald M. W. (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 46, 388-393.
123. Sanford L. D., Morrison A. R., Mann G. L., Harris J. S., Yoo L., and Ross R. J. (1994) Sleep pattering and behaviour in cats with pontine lesions creating REM without atonia. J. Sleep Res. 3, 233-240.
124. Lavoie B., Smith Y., and Parent A. (1989) Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry. J. Comp. Neurol. 289, 36-52.
125. Fallon J. H. and Moore R. Y. (1978) Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180, 545-580.
126. Vertes R. P. (1988) Brainstem afferents to the basal forebrain in the rat. Neuroscience 24, 907-935.